These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34431466)

  • 21. The hypoxia conditioned mesenchymal stem cells promote hepatocellular carcinoma progression through YAP mediated lipogenesis reprogramming.
    Liu Y; Ren H; Zhou Y; Shang L; Zhang Y; Yang F; Shi X
    J Exp Clin Cancer Res; 2019 May; 38(1):228. PubMed ID: 31142342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma.
    Tu K; Yang W; Li C; Zheng X; Lu Z; Guo C; Yao Y; Liu Q
    Mol Cancer; 2014 May; 13():110. PubMed ID: 24884509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aloperine induces apoptosis and G2/M cell cycle arrest in hepatocellular carcinoma cells through the PI3K/Akt signaling pathway.
    Liu JS; Huo CY; Cao HH; Fan CL; Hu JY; Deng LJ; Lu ZB; Yang HY; Yu LZ; Mo ZX; Yu ZL
    Phytomedicine; 2019 Aug; 61():152843. PubMed ID: 31039533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activating the Hippo pathway by nevadensin overcomes Yap-drived resistance to sorafenib in hepatocellular carcinoma.
    Shi H; Zou Y; Wang X; Wang G; Gao Y; Yi F; Xu J; Yin Y; Li D; Li M
    Discov Oncol; 2023 May; 14(1):83. PubMed ID: 37243813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TNFAIP8 interacts with LATS1 and promotes aggressiveness through regulation of Hippo pathway in hepatocellular carcinoma.
    Dong Q; Fu L; Zhao Y; Xie C; Li Q; Wang E
    Oncotarget; 2017 Feb; 8(9):15689-15703. PubMed ID: 28152516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knockdown of yes-associated protein inhibits proliferation and downregulates large tumor suppressor 1 expression in MHCC97H human hepatocellular carcinoma cells.
    Wang C; Zhu ZM; Liu CL; He XJ; Zhang HY; Dong JH
    Mol Med Rep; 2015 Jun; 11(6):4101-8. PubMed ID: 25625370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dichloroacetate attenuates the stemness of hepatocellular carcinoma cells via promoting nucleus-cytoplasm translocation of YAP.
    Su D; Lin Z
    Environ Toxicol; 2021 May; 36(5):975-983. PubMed ID: 33405312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct and Overlapping Roles of Hippo Effectors YAP and TAZ During Human and Mouse Hepatocarcinogenesis.
    Wang H; Wang J; Zhang S; Jia J; Liu X; Zhang J; Wang P; Song X; Che L; Liu K; Ribback S; Cigliano A; Evert M; Wu H; Calvisi DF; Zeng Y; Chen X
    Cell Mol Gastroenterol Hepatol; 2021; 11(4):1095-1117. PubMed ID: 33232824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TAZ target gene ITGAV regulates invasion and feeds back positively on YAP and TAZ in liver cancer cells.
    Weiler SME; Lutz T; Bissinger M; Sticht C; Knaub M; Gretz N; Schirmacher P; Breuhahn K
    Cancer Lett; 2020 Mar; 473():164-175. PubMed ID: 31904487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrin α2β1 inhibits MST1 kinase phosphorylation and activates Yes-associated protein oncogenic signaling in hepatocellular carcinoma.
    Wong KF; Liu AM; Hong W; Xu Z; Luk JM
    Oncotarget; 2016 Nov; 7(47):77683-77695. PubMed ID: 27765911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A FUS-LATS1/2 Axis Inhibits Hepatocellular Carcinoma Progression via Activating Hippo Pathway.
    Bao L; Yuan L; Li P; Bu Q; Guo A; Zhang H; Cui N; Liu B
    Cell Physiol Biochem; 2018; 50(2):437-451. PubMed ID: 30308519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myricetin Suppresses the Propagation of Hepatocellular Carcinoma via Down-Regulating Expression of YAP.
    Li M; Chen J; Yu X; Xu S; Li D; Zheng Q; Yin Y
    Cells; 2019 Apr; 8(4):. PubMed ID: 30999669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tadalafil enhances the therapeutic efficacy of BET inhibitors in hepatocellular carcinoma through activating Hippo pathway.
    Kong D; Jiang Y; Miao X; Wu Z; Liu H; Gong W
    Biochim Biophys Acta Mol Basis Dis; 2021 Dec; 1867(12):166267. PubMed ID: 34508829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic Hippo signaling inhibits development of hepatocellular carcinoma.
    Liu Y; Wang X; Yang Y
    Clin Mol Hepatol; 2020 Oct; 26(4):742-750. PubMed ID: 32981290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retinal dehydrogenase 5 (RHD5) attenuates metastasis via regulating HIPPO/YAP signaling pathway in Hepatocellular Carcinoma.
    Hu H; Xu L; Luo SJ; Xiang T; Chen Y; Cao ZR; Zhang YJ; Mo Z; Wang Y; Meng DF; Yu L; Lin LZ; Zhang SJ
    Int J Med Sci; 2020; 17(13):1897-1908. PubMed ID: 32788868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hippo signaling pathway in companion animal diseases, an under investigated signaling cascade.
    Budel SJ; Penning MM; Penning LC
    Vet Q; 2021 Dec; 41(1):172-180. PubMed ID: 33945400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activated hippo signal pathway inhibits cell proliferation and promotes apoptosis in NK/T cell lymphoma cells.
    Chang Y; Fu XR; Cui M; Li WM; Zhang L; Li X; Li L; Sun ZC; Zhang XD; Li ZM; You XY; Nan FF; Wu JJ; Wang XH; Zhang MZ
    Cancer Med; 2019 Jul; 8(8):3892-3904. PubMed ID: 31124291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcatheter arterial chemoembolization combined with Hippo/YAP inhibition significantly improve the survival of rats with transplanted hepatocellular carcinoma.
    Quan Y; Li Z; Zhu K; Liang J
    Lipids Health Dis; 2021 Jul; 20(1):74. PubMed ID: 34304741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CXCR4 mediates matrix stiffness-induced downregulation of UBTD1 driving hepatocellular carcinoma progression via YAP signaling pathway.
    Yang N; Chen T; Wang L; Liu R; Niu Y; Sun L; Yao B; Wang Y; Yang W; Liu Q; Tu K; Liu Z
    Theranostics; 2020; 10(13):5790-5801. PubMed ID: 32483419
    [No Abstract]   [Full Text] [Related]  

  • 40. LncRNA PCAT6 predicts poor prognosis in hepatocellular carcinoma and promotes proliferation through the regulation of cell cycle arrest and apoptosis.
    Luo Y; Lin J; Zhang Y; Dai G; Li A; Liu X
    Cell Biochem Funct; 2020 Oct; 38(7):895-904. PubMed ID: 32064636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.